Sutro Biopharma, Inc. announced a collaboration with Sanofi Pasteur Limited to produce two undisclosed vaccine candidates. This collaboration highlights the potential value of Sutro's biochemical synthesis technology for the production of vaccines and provides additional validation of the benefits of the company's technology platform.